ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.93
      0.25%
      US Tech 100
      19,429.20
      0.56%
      Dow Jones
      42,208.22
      0.20%
      Brent Oil
      74.56
      1.12%
      Bitcoin
      64,458.50
      1.79%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Ariad Pharmaceuticals, Inc. (ARIA) Quote

      Ariad Pharmaceuticals, Inc.

      Ariad Pharmaceuticals, Inc. (ARIA)

      NASDAQ
      23.99
      0.00
      (0.00%)
      At close: September 24 4:00PM
      Delayed by 15 minutes
      23.99
      0.00
      ( 0.00% )
      After Hours: -
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      23.99
      Bid
      23.80
      Ask
      22.88
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      23.99
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      ARIA Latest News

      More News

      FeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

      10 hours ago

      FeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

      10 hours ago

      ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency

      ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the submission of a Marketing Authorization Application (MAA) for its investigational oral anaplastic lymphoma kinase (ALK...

      February 06 2017
      Business Wire

      Ariad Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of ARIA Shareholders

      Ariad Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of ARIA Shareholders PR Newswire NEW YORK, Jan. 18, 2017 NEW YORK, Jan. 18, 2017 /PRNewswire/ -- WeissLaw LLP is...

      January 18 2017
      PR Newswire (US)

      Harwood Feffer LLP Announces Investigation of ARIAD Pharmaceuticals, Inc.

      Harwood Feffer LLP Announces Investigation of ARIAD Pharmaceuticals, Inc. PR Newswire NEW YORK, Jan. 9, 2017 NEW YORK, Jan. 9, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is...

      January 09 2017
      PR Newswire (US)

      ARIAD PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

      Rigrodsky & Long, P.A.: Do you own shares of ARIAD Pharmaceuticals, Inc. (NASDAQ GS: ARIA)? Did you purchase any of your shares prior to January 9, 2017? Do you think the...

      January 09 2017
      Business Wire

      ARIAD Enters into Definitive Agreement to Be Acquired by Takeda for $5.2 Billion

      ARIAD Stockholders to Receive $24.00 per Share in Cash ARIAD Pharmaceuticals (NASDAQ:ARIA) (“ARIAD”) today announced it has entered into a definitive agreement to be acquired by Takeda...

      January 09 2017
      Business Wire

      Takeda to Acquire ARIAD Pharmaceuticals, Inc.

      – Significantly Enhances Takeda’s Global Oncology Portfolio – – Accretive to FY2018 Underlying Core Earnings – – Reinforces Takeda’s Commitment to Developing Medicines for Patients...

      January 09 2017
      Business Wire

      ARIAD to Present at the 35th Annual J.P. Morgan Healthcare Conference

      ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA), a rare cancer-focused innovative biotechnology company, today announced that it will present at the 35th Annual J.P. Morgan Healthcare...

      January 03 2017
      Business Wire

      Traders News Issues New Reports and Features a New OTCQB Company Profile

      ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. The company has...

      December 13 2016
      InvestorsHub NewsWire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ELYMEliem Therapeutics Inc
      $ 10.13
      (54.42%)
      		1.1M
      MSGMMotorsport Games Inc
      $ 1.46
      (32.73%)
      		2.52M
      XHGXChange TED Inc
      $ 1.5501
      (29.18%)
      		2.76M
      GIFTRDE Inc
      $ 3.1999
      (26.98%)
      		1.6k
      FEAM5E Advanced Materials Inc
      $ 0.476
      (16.55%)
      		1.5k
      SFIXStitch Fix Inc
      $ 2.9201
      (-22.13%)
      		1.13M
      POLAPolar Power Inc
      $ 0.4524
      (-12.50%)
      		50.95k
      ATXSAstria Therapeutics Inc
      $ 10.99
      (-12.08%)
      		50.02k
      TRNRInteractive Strength Inc
      $ 0.2357
      (-10.04%)
      		1.23M
      ULYUrgent ly Inc
      $ 0.713
      (-8.44%)
      		7.38k
      INTCIntel Corporation
      $ 22.80
      (-0.04%)
      		17.34M
      NVDANVIDIA Corporation
      $ 121.26
      (0.32%)
      		14.54M
      JGLOJP Morgan Global Select Equity ETF
      $ 62.28
      (0.00%)
      		13.85M
      ELABElevai Labs Inc
      $ 0.115
      (11.65%)
      		10.59M
      LIPOLipella Pharmaceuticals Inc
      $ 0.50
      (10.35%)
      		6.36M

      Discussion

      View Full Feed
      Threeflight Threeflight 29 seconds ago
      The thing is almost no OTC/pink or even Big Board SPAC's have done anything the past 4 years as far as RM's and acquisitions. That is because Biden's inflationary spending has caused the FED to increase interest rates to the point where any sort of those types of events cannot happen due to the exp
      AVVH
      Giovanni Giovanni 31 seconds ago
      You will lose on this bet.
      XXII
      northam43 northam43 34 seconds ago
      Report 7.1 SPX Cycles Long Range Projection Chart. Today the SPX put in another new ATH at 5735.32. The Weekly, Monthly, Quarterly & Yearly Cycles all put in new highs today at 5735.32. Possibility of a Weekly W-E-2 at the close on 10/4/24, projected high 6227.85, the high will be due 12/27/24.
      cjstocksup cjstocksup 35 seconds ago
      I cannot see them. HMMMM
      working OK-- a few times today there were problems
      DesertDrifter DesertDrifter 40 seconds ago
      The Chief is mastering the political double-talk. I met him long ago when it was clear what job he was being groomed for. In one of the articles, he mentions 157 people will still be in play for one thing or another. That is pretty weak when there are 30,000 employees. hiring from within means g
      ITYS ITYS 1 minute ago
      FACT CHECK,--- AGAIN, seems clowns are trying to distort the truth about Coronacide and THIS IS PROOF clowns are again WRONG !
      SO here is truth with factual DD.

      Coronacide filed lawsuit against Wellness Matrix

      CoronaCide Test Kits
      https://cases.justia.com
      MGON
      Giovanni Giovanni 1 minute ago
      LOL

      You will learn that means absolutly zero
      XXII
      cjstocksup cjstocksup 1 minute ago
      https://x.com/elonmusk/status/1838527740154130596
      JACKPOT JACKPOT 1 minute ago
      Over $10, who would have ever thought that, ey! 🤣
      BGC
      northam43 northam43 2 minutes ago
      Report 7.1 SPX Cycles Long Range Projection Chart. Today the SPX put in another new ATH at 5735.32. The Weekly, Monthly, Quarterly & Yearly Cycles all put in new highs today at 5735.32. Possibility of a Weekly W-E-2 at the close on 10/4/24, projected high 6227.85, the high will be due 12/27/24.
      JustGoDeep JustGoDeep 2 minutes ago
      Bashing Biel For Bashings Sake!! UTTER NONSENSE!!
      BIEL
      JoshTaeger JoshTaeger 2 minutes ago
      Thanks. BTW, the 59th State is on ignore
      SHMP
      Dennis14 Dennis14 3 minutes ago
      More buys than sells.
      APVO
      Dennis14 Dennis14 3 minutes ago
      More buys than sells.
      APVO
      mick mick 4 minutes ago
      Forget Tesla. Here's a Better Robotaxi Stock. $UBER ????? robotaxi and vehicle autonomy thesis

      https://youtu.be/h3gb23YB8Xg
      UBER
      ksquared ksquared 4 minutes ago
      omg That was some serious dental surgery.
      Here's to some serious healing and heavy-duty painkillers.
      Good luck to Marc... and to you. Take care.
      LOCOGOD LOCOGOD 4 minutes ago
      LOL. Yeah ok.  They should have sold 3 years ago when it was .02.  Cry me a river.
      PHIL
      azhector31 azhector31 4 minutes ago
      can a moderator get rid of this person??
      ICTY
      thegoodnessparadox thegoodnessparadox 5 minutes ago
      Note conversion is not an issue here.
      GNCP
      azhector31 azhector31 5 minutes ago
      yea
      holding
      ICTY
      excel excel 5 minutes ago
      Just read they lost two defensive starters so I'll take it.

      Read how they won the games they did so far.

      Very lucky like the Seahawks. LOL!
      Investor082 Investor082 6 minutes ago
      I made it so easy for you and yet you display no confidence in LP and LG.

      All I asked is that combo trial deal must pay NWBO. I removed big pharma and greater than $100M payout terms from my original proposal.

      As a shareholder, I’d be interested if a company is payin
      NWBO
      peteypickem peteypickem 6 minutes ago
      Easy solution :::: if you don’t like a stock your in sell and move on,, your not trading Microsoft or Apple in this arena
      ILST
      GLENO34 GLENO34 6 minutes ago
      5821 Possible target ...Guru call. And strong REZ.

      Your Recent History

      NASDAQ
      ARIA
      Ariad
      Delayed Upgrade Clock